To disambiguate the function of macroH2A2 in epigenetic programs of GBM, we performed the sequencing-based assay for transposase-accessible chromatin (ATAC-seq)76,77 in our patient-derived dox-inducible knockdown models. The gene discussed is MACROH2A2; the disease is glioblastoma.